Cargando…

Clinical correlates of circulating cell-free DNA tumor fraction

BACKGROUND: Oncology applications of cell-free DNA analysis are often limited by the amount of circulating tumor DNA and the fraction of cell-free DNA derived from tumor cells in a blood sample. This circulating tumor fraction varies widely between individuals and cancer types. Clinical factors that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bredno, Joerg, Lipson, Jafi, Venn, Oliver, Aravanis, Alexander M., Jamshidi, Arash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386888/ https://www.ncbi.nlm.nih.gov/pubmed/34432811 http://dx.doi.org/10.1371/journal.pone.0256436

Ejemplares similares

KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients
por: Wang, Zhe-Ying, et al.
Publicado: (2019)

Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis
por: Zhou, Xiao, et al.
Publicado: (2022)

A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
por: Larson, Matthew H., et al.
Publicado: (2021)

Author Correction: A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
por: Larson, Matthew H., et al.
Publicado: (2022)

Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples
por: Husain, Hatim, et al.
Publicado: (2022)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
por: Razavi, Pedram, et al.
Publicado: (2019)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer
por: Riethdorf, Sabine, et al.
Publicado: (2017)

Publisher Correction: Tumor fractions deciphered from circulating cell-free DNA methylation for cancer early diagnosis
por: Zhou, Xiao, et al.
Publicado: (2023)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2022)

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
por: Openshaw, Mark R., et al.
Publicado: (2015)

Remote immune processes revealed by immune-derived circulating cell-free DNA
por: Fox-Fisher, Ilana, et al.
Publicado: (2021)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer
por: Patel, Hitendra, et al.
Publicado: (2019)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma
por: Nabavizadeh, Seyed Ali, et al.
Publicado: (2020)

A DNA methylation atlas of normal human cell types
por: Loyfer, Netanel, et al.
Publicado: (2023)

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
por: Tsui, Dana W. Y., et al.
Publicado: (2021)

Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Qualitative and Quantitative Image-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
por: Golden, Daniel I., et al.
Publicado: (2018)

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
por: Lowes, Lori E., et al.
Publicado: (2016)

The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
por: Henriksen, Tenna V., et al.
Publicado: (2020)

Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker
por: Wang, Ru, et al.
Publicado: (2017)

Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial Sarcomas
por: Eisenhardt, Anja E., et al.
Publicado: (2022)

Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
por: Clark, Travis A., et al.
Publicado: (2018)

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors
por: Kujala, Jouni, et al.
Publicado: (2022)

Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA
por: Cutts, Anthony, et al.
Publicado: (2017)

Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation
por: Cuadrat, Rafael R C, et al.
Publicado: (2023)

Clinical utility of circulating cell-free DNA in advanced colorectal cancer
por: Pereira, Allan A. Lima, et al.
Publicado: (2017)

Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2021)

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
por: Lanman, Richard B., et al.
Publicado: (2015)

Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction
por: Santoro, Graziano, et al.
Publicado: (2021)

Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
por: Yu, Pengjie, et al.
Publicado: (2022)

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
por: Manier, S., et al.
Publicado: (2018)

Circulating Cell-Free DNA Correlates with Body Integral Dose and Radiation Modality in Prostate Cancer
por: Lockney, Natalie A., et al.
Publicado: (2020)

Mitochondrial Health Index Correlates with Plasma Circulating Cell-Free Mitochondrial DNA in Bipolar Disorder
por: Scaini, Giselli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0pjfoqj49f0hehcovj23cf12kk